Akèy › Maladi Alzheimer › Florid › Tampa
Etid klinik pou Maladi Alzheimer nan Tampa, FL
17 etid pou Maladi Alzheimer ap chèche patisipan nan sit nan ak bò kote Tampa (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
Ap rekriteFaz 2
- Clinical Site, Tampa
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
Ap rekriteFaz 2
- University of South Florida, Tampa
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
Ap rekriteFaz 3
- IPTB Clinical Research, Tampa
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Ap rekriteFaz 3
- Guardian Angel Research, Tampa
- Interventional Psychiatry of Tampa Bay, Tampa
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Ap rekriteFaz 2
- Axiom Brain Health LLC, Tampa
Microbiome in Aging of Gut and Brain
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Department of Neurosurgery and Brain and Spine and Faculty of USF Center for Microbiome Re-search, Microbiomes Institute, Tampa
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Ap rekriteFaz 3
- Axiom Brain Health LLC, Tampa
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
Ap rekriteFaz 3
- USF Health Byrd Alzheimer's Institute, Tampa
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
Ap rekriteFaz 3
- IPTB Clinical Research, Tampa
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
Ap rekriteFaz 2
- Local Institution - 0001, Tampa
- Local Institution - 0080, Tampa
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
Ap rekriteFaz 2
- Axiom Brain Health ( Site 1029), Tampa
- K2 Medical Research ( Site 1020), Tampa
AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980)
Ap rekriteFaz 1
- University of South Florida, Tampa
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Ap rekriteFaz 3
- Care Access - Tampa, Tampa
- K2 Medical Research - Tampa, Tampa
A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
Ap rekriteFaz 1Volontè an sante akeyi
- K2 Medical Research - Tampa, Tampa
Palliative Care Education in Assisted Living for Dementia Care Providers (PCEAL-DCP)
Ap rekriteVolontè an sante akeyi
- University of South Florida, Tampa
- University of South Florida, Tampa
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Axiom Brain Health, Tampa
ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease
Ap rekrite
- Tampa General Hospital, Tampa
Etid Maladi Alzheimer nan lòt vil
- Boston, MA26 etid
- Orlando, FL25 etid
- St. Louis, MO22 etid
- New York City, NY21 etid
- Miami, FL20 etid
- Atlanta, GA16 etid
- Philadelphia, PA15 etid
- The Villages, FL15 etid
- Phoenix, AZ15 etid
- Indianapolis, IN14 etid
- Los Angeles, CA14 etid
- West Palm Beach, FL13 etid
Lòt etid nan Tampa
- Kansè Poumon ki pa ti selil51 etid
- Kansè nan tete43 etid
- Kansè (tout kalite)39 etid
- Kansè kolorektal34 etid
- Leksemi mieloïd egi29 etid
- Kansè Metastatik29 etid
- Kansè poumon29 etid
- Kansè pankreyas26 etid
- Kansè ovè21 etid
- Melanom19 etid
- Sendwòm myelodisplastik19 etid
- Kansè pwostat18 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.